Axovant Gene Therapies (NASDAQ:AXGT) Research Coverage Started at Svb Leerink

Axovant Gene Therapies (NASDAQ:AXGT) Research Coverage Started at Svb Leerink

Svb Leerink started coverage on shares of Axovant Gene Therapies (NASDAQ:AXGT) in a research note published on Friday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $18.00 target price on the stock. Svb Leerink... 
Crocs (NASDAQ:CROX) Lifted to Outperform at Robert W. Baird

Crocs (NASDAQ:CROX) Lifted to Outperform at Robert W. Baird

Robert W. Baird upgraded shares of Crocs (NASDAQ:CROX) from a neutral rating to an outperform rating in a research note issued to investors on Friday, Benzinga reports. Robert W. Baird currently has $29.00 target price on the textile... 
ValuEngine Upgrades DexCom (NASDAQ:DXCM) to Strong-Buy

ValuEngine Upgrades DexCom (NASDAQ:DXCM) to Strong-Buy

ValuEngine upgraded shares of DexCom (NASDAQ:DXCM) from a buy rating to a strong-buy rating in a research report report published on Friday, ValuEngine reports. Other analysts have also recently issued reports about the stock. BidaskClub... 
Insider Selling: Guidewire Software Inc (NYSE:GWRE) CEO Sells $969,828.52 in Stock

Insider Selling: Guidewire Software Inc (NYSE:GWRE) CEO Sells $969,828.52 in Stock

Guidewire Software Inc (NYSE:GWRE) CEO Marcus Ryu sold 9,748 shares of the company’s stock in a transaction on Wednesday, June 19th. The shares were sold at an average price of $99.49, for a total transaction of $969,828.52.... 
LPL Financial (NASDAQ:LPLA) Stock Rating Lowered by BidaskClub

LPL Financial (NASDAQ:LPLA) Stock Rating Lowered by BidaskClub

LPL Financial (NASDAQ:LPLA) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a research report issued on Saturday, BidAskClub reports. Other equities research analysts have also issued... 
Insider Selling: Zscaler Inc (NASDAQ:ZS) EVP Sells 18,000 Shares of Stock

Insider Selling: Zscaler Inc (NASDAQ:ZS) EVP Sells 18,000 Shares of Stock

Zscaler Inc (NASDAQ:ZS) EVP Amit Sinha sold 18,000 shares of the stock in a transaction that occurred on Thursday, June 20th. The stock was sold at an average price of $80.78, for a total value of $1,454,040.00. The sale was disclosed... 
Bank of America Raises Merck & Co., Inc. (NYSE:MRK) Price Target to $96.00

Bank of America Raises Merck & Co., Inc. (NYSE:MRK) Price Target to $96.00

Merck & Co., Inc. (NYSE:MRK) had its price objective increased by Bank of America from $91.00 to $96.00 in a research note released on Friday, The Fly reports. Other research analysts also recently issued reports about the stock.... 
Axsome Therapeutics (NASDAQ:AXSM) Downgraded by Zacks Investment Research

Axsome Therapeutics (NASDAQ:AXSM) Downgraded by Zacks Investment Research

Zacks Investment Research cut shares of Axsome Therapeutics (NASDAQ:AXSM) from a hold rating to a sell rating in a research note issued to investors on Friday, Zacks.com reports. According to Zacks, “Axsome Therapeutics, Inc.... 
Financial Contrast: Gladstone Land (NASDAQ:LAND) and Four Corners Property Trust (NASDAQ:FCPT)

Financial Contrast: Gladstone Land (NASDAQ:LAND) and Four Corners Property Trust (NASDAQ:FCPT)

Gladstone Land (NASDAQ:LAND) and Four Corners Property Trust (NYSE:FCPT) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations,... 
Head to Head Comparison: Technicolor (OTCMKTS:TCLRY) vs. Sonos (OTCMKTS:SONO)

Head to Head Comparison: Technicolor (OTCMKTS:TCLRY) vs. Sonos (OTCMKTS:SONO)

Technicolor (OTCMKTS:TCLRY) and Sonos (NASDAQ:SONO) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends,... 
Arcturus Therapeutics (NASDAQ:ARCT) Given a $18.00 Price Target by Chardan Capital Analysts

Arcturus Therapeutics (NASDAQ:ARCT) Given a $18.00 Price Target by Chardan Capital Analysts

Chardan Capital set a $18.00 target price on Arcturus Therapeutics (NASDAQ:ARCT) in a research note published on Thursday morning, Stock Target Advisor reports. The firm currently has a buy rating on the biotechnology company’s... 
Melinta Therapeutics (NASDAQ:MLNT) Receives “Sell” Rating from Gabelli

Melinta Therapeutics (NASDAQ:MLNT) Receives “Sell” Rating from Gabelli

Gabelli reissued their sell rating on shares of Melinta Therapeutics (NASDAQ:MLNT) in a report published on Thursday, Stock Target Advisor reports. A number of other brokerages also recently weighed in on MLNT. JPMorgan Chase &... 
BioNano Genomics (NASDAQ:BNGO) Stock Rating Reaffirmed by Maxim Group

BioNano Genomics (NASDAQ:BNGO) Stock Rating Reaffirmed by Maxim Group

Maxim Group reiterated their buy rating on shares of BioNano Genomics (NASDAQ:BNGO) in a research note released on Thursday morning, AnalystRatings.com reports. Maxim Group currently has a $11.00 target price on the stock. “Bionano’s... 
Shopify (NYSE:SHOP) Rating Reiterated by Canaccord Genuity

Shopify (NYSE:SHOP) Rating Reiterated by Canaccord Genuity

Canaccord Genuity restated their buy rating on shares of Shopify (NYSE:SHOP) (TSE:SHOP) in a research report report published on Thursday, Briefing.com Automated Import reports. The brokerage currently has a $360.00 target price on... 
Victory Capital (NASDAQ:VCTR) Downgraded by Zacks Investment Research

Victory Capital (NASDAQ:VCTR) Downgraded by Zacks Investment Research

Zacks Investment Research cut shares of Victory Capital (NASDAQ:VCTR) from a hold rating to a strong sell rating in a research report released on Thursday, Zacks.com reports. According to Zacks, “Victory Capital Holdings, Inc....